港燈(02638.HK)與國家電網南瑞集團簽訂合作協議
港燈(02638.HK)宣布,今日(14日)與國家電網旗下南瑞集團簽訂合作協議,探索在優化港燈電網營運等領域展開合作。按照框架協議,南瑞將透過最先進的遠動終端裝置,參考國家電網現行的設計,提供方案以提升港燈電力系統的遙距監控,從而邁向全面自動化。
港燈董事總經理鄭祖瀛指,南瑞在內地及海外擁有高端技術以及豐富的實踐經驗,深信透過雙方合作交流,港燈可全面強化電網,進一步提升供電可靠性,配合香港社會發展的用電需求,同時亦為未來由內地輸入零碳能源及早做好準備。
另外,為配合香港政府計劃在未來由內地輸入更多零碳能源,港燈正積極準備,著手研究和規劃如何能夠安全穩定地把由內地輸入的零碳電力接駁上本身電網。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.